Pediatric Screening for Elevated Lead Levels evaluation

American Academy of Family Physicians' (AAFP) - CME Credit Determination
The AAFP has reviewed Pediatric Screening for Elevated Lead Levels and deemed it acceptable for up to 1.00 Enduring Materials, Self-Study AAFP Prescribed credit. Term of Approval is from 04/18/2021 to 04/18/2022. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Board of Registered Nursing - CE credit determination

Provider approved by the California Board of Registered Nursing, Provider Number CEP16728, for 1.00 contact hour(s).

Question Title

* 1. Information

Name

Company

Title

License number

County

Email Address

Question Title

* 2. What new knowledge or clinical pearl will you apply in your practice as a result of this educational activity?

Question Title

* 3. According to DHCS and the Centers for Disease Control, which of the following children covered by MediCal need not be screened for elevated lead levels

a. Age 6 months

b. Age 12 months

c. Age 18 months with no prior lead test done

d. Age 24 months with a prior lead test done at 12 months of age

e. Age 3 years with no prior lead test done

Question Title

* 4. A 13 month old child with no known lead exposure risk has a capillary lead test result of 12 micrograms per dL. What are the next steps (more than one may apply)?

a. Review the results with the parents asking closely about potential lead exposures

b. Order a venous blood test for lead level

c. Order a hemoglobin and iron test

d. Admit the child to the hospital for chelation therapy

e. Nutritional counselling to increase iron and calcium uptake

f. Review the most recent well child visit to see if any neurodevelopmental issues were identified.

Question Title

* 5. Mild elevate blood lead levels (1-4 micrograms per deciliter) in children can have life-long effects on the brain.

True

False